SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Apollo Hospitals gains on the buzz of targeting to add 2500 beds in next three-year

19 Jul 2017 Evaluate

Apollo Hospitals Enterprise is currently trading at Rs. 1251.85, up by 8.75 points or 0.70% from its previous closing of Rs. 1243.10 on the BSE.

The scrip opened at Rs. 1250.00 and has touched a high and low of Rs. 1253.25 and Rs. 1241.85 respectively. So far 3048 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1442.75 on 09-Aug-2016 and a 52 week low of Rs. 1110.75 on 26-Dec-2016.

Last one week high and low of the scrip stood at Rs. 1259.75 and Rs. 1228.55 respectively. The current market cap of the company is Rs. 17416.38 crore.

The promoters holding in the company stood at 34.35%, while institutions and non-institutions held 55.99% and 8.85% respectively.

Apollo Hospitals is reportedly planning to add around 2,500 more beds in next three-year expansion plan. The company has planned the same after achieving a target of 10,000 beds capacity.

The company would have speciality beds for cardiology and cancer and would expand to other cities where it does not have the presence and also to increase the beds in cities where it is already present in.

The company, in the 36 months ending March 31, 2017, has commissioned 2,430 beds in 13 locations including a 480-bed facility in Navi Mumbai. During the 2018-19, the Navi Mumbai facility is expected to see an expansion into oncology apart from the addition of 65 beds in Indore hospital and a proton therapy centre to treat cancer with 200 beds in South Chennai. Besides, the current expansion plan is to add another 500 bed in a hospital in Byculla, Mumbai, for Rs 350 crore in FY22.

Apollo Hospital Ent. Share Price

7699.05 143.10 (1.89%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×